Product Description
Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors, offering a multifaceted approach to energy regulation, fat metabolism, and appetite control.
By stimulating glucagon production, It promotes the breakdown of stored fats and glycogen, enhancing basal metabolic rate. Its dual action on GLP-1 and GIP receptors supports delayed gastric emptying and improved satiety, making it a promising candidate in obesity and metabolic disorder studies.